e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can we predict tuberculosis cure? What tools are available?
Delia Goletti, Cecilia S. Lindestam Arlehamn, Thomas J. Scriba, Richard Anthony, Daniela Maria Cirillo, Tonino Alonzi, Claudia M. Denkinger, Frank Cobelens
Source:
Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018
Journal Issue:
November
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Delia Goletti, Cecilia S. Lindestam Arlehamn, Thomas J. Scriba, Richard Anthony, Daniela Maria Cirillo, Tonino Alonzi, Claudia M. Denkinger, Frank Cobelens. Can we predict tuberculosis cure? What tools are available?. Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
What do new data concerning triple therapy tell us about the risk of infection?
Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection
Year: 2019
TB following targeted and biological therapy: can we predict it?
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
How can we achieve better prevention of progression to tuberculosis among contacts?
Source: Eur Respir J 2013; 42: 1743-1746
Year: 2013
Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
Will clinicians keep their place in modern management of tuberculosis?
Source: Eur Respir J 2001; 18: Suppl. 33, 474s
Year: 2001
Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also?
Source: Eur Respir J 2006; 28: Suppl. 50, 21s
Year: 2006
Are
in vitro
sensitivity tests for tuberculosis drugs a good guide of clinical outcome?
Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level
Year: 2006
How quickly do we identify and treat patients with TB ?
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009
Should we treat every patient with latent TB? Is there a cost to pay?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
MDR-TB management: what is new?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018
Do we need bacteriological confirmation of cure in uncomplicated tuberculosis?
Source: Eur Respir J 2013; 42: 860-863
Year: 2013
Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
What do they know about TB?
Source: Eur Respir J 2002; 20: Suppl. 38, 163s
Year: 2002
Steroids related tuberculosis: Does a subgroup require a more cautious approach?
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is “blind” treatment dangerous?
Source: Eur Respir J 2011; 37: 1283-1285
Year: 2011
Which are the best methods to manage COPD patients in the post-COVID era?
Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era
Year: 2021
What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline?
Source: ERS Research Seminar 2016
Year: 2016
TB disease and infection. Do we have real news?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Individualising treatment for tuberculosis: what has whole genome sequencing taught us so far?
Source: Virtual Congress 2020 – Respiratory infections
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept